Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 4 results

Name	Type of Offering	Accepted Date
DalCor Pharmaceuticals US, LLC See All Filings	D/A	2020-09-14 14:21:35 UTC
Amount To Be Raised $3,851,699 Associated Brokers / Dealers N/A CIK Number 0001673368 Filed Document 0001673368-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-09-14 14:21:35 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
DalCor Pharmaceuticals US, LLC See All Filings	D	2020-05-27 13:29:27 UTC
Amount To Be Raised $2,845,541 Associated Brokers / Dealers N/A CIK Number 0001673368 Filed Document 0001673368-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-05-27 13:29:27 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
DalCor Pharmaceuticals US, LLC See All Filings	D/A	2017-05-12 12:14:00 UTC
Amount To Be Raised $110,000,000 Associated Brokers / Dealers N/A CIK Number 0001673368 Filed Document 0001673368-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-05-12 12:14:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
DalCor Pharmaceuticals US, LLC See All Filings	D	2016-05-13 00:00:00 UTC
Amount To Be Raised $110,000,000 Associated Brokers / Dealers N/A CIK Number 0001673368 Filed Document 0001673372-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-05-13 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity